Literature DB >> 8510893

Long-term visual outcome and complications associated with pars planitis.

S M Malinowski1, J S Pulido, J C Folk.   

Abstract

PURPOSE: To identify the ocular complications and to statistically evaluate the possible association of pars planitis with multiple sclerosis (MS) in a homogeneous population of pars planitis patients.
METHODS: The authors reexamined 36 patients and reviewed the records of an additional 18 patients (total: 54 patients, 108 eyes) with idiopathic pars planitis.
RESULTS: The initial mean visual acuity of 20/46 (logMAR: 0.36 +/- 0.50) was not statistically different from the final mean visual acuity of 20/44 (logMAR: 0.34 +/- 0.45; P = 0.73), after a mean follow-up of 89.2 months. Complications included neovascularization with or without associated vitreous hemorrhage (7 eyes, 6.5%), moderate to severe cellophane retinopathy (7 eyes, 6.5%), chronic cystoid macular edema (CME) (9 eyes, 8.3%), visually significant cataracts (16 eyes, 14.8%), and retinal detachment (9 eyes, 8.3%). Significant lens opacification was associated with a greater risk of retinal detachment (P = 0.004). In four patients (7.4%), optic neuritis developed, and in an additional eight patients (14.8%) MS developed. Kaplan-Meier analysis of these data showed a 16.2% +/- 6.2% risk of MS solely developing in patients, and a 20.4% +/- 6.7% risk of either MS or optic neuritis developing, after 5 years of disease. The presence of periphlebitis at the time of pars planitis diagnosis increased the rate of development of these conditions (P = 0.002). Six patients (11.1%) had a family history positive for MS in a first-degree relative.
CONCLUSIONS: This study demonstrates the overall favorable visual prognosis in patients with pars planitis. Patients with significant cataract formation appear to be at greater risk for retinal detachment. Periphlebitis at the time of diagnosis of pars planitis increases the risk of development of optic neuritis or MS. The strong association demonstrated between pars planitis and MS in this study further supports a link between the two disease states.

Entities:  

Mesh:

Year:  1993        PMID: 8510893     DOI: 10.1016/s0161-6420(93)31567-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  47 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

Authors:  B van Kooij; M Canninga van Dijk; J de Boer; V Sigurdsson; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Patients with retinal vasculitis rarely suffer from systemic vasculitis.

Authors:  James T Rosenbaum; Jennifer Ku; Amro Ali; Dongseok Choi; Eric B Suhler
Journal:  Semin Arthritis Rheum       Date:  2011-12-15       Impact factor: 5.532

4.  [Vision-threatening complications in childhood uveitis].

Authors:  A Mingels; T Hudde; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

5.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

Review 6.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

7.  Ultrasound biomicroscopic imaging in intermediate uveitis.

Authors:  G Häring; B Nölle; B Wiechens
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

Review 8.  Intermediate uveitis.

Authors:  B Manohar Babu; S R Rathinam
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

9.  Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; C E Hack; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

Review 10.  [Uveitis in multiple sclerosis : Overview and perspectives].

Authors:  A L Hildebrandt; F Mackensen
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.